Call for Autism Case Studies

Calling all physicians! 

If you are a specialist treating a patient with autism with comorbidities and are using any of the next generation drugs like:

• MAB drugs like Humira/Enbrel/Stelara
• mTOR inhibitors like sirolimus and everolimus
• JAK inhibitors like Rinvoq and Baricitinib
• or any other drug not studied for autism.

We invite you to submit one or more case studies describing their effects on autism core symptoms.

Please use this form to submit details. You will be awarded a mini grant of $2000 for each selected case study you submit.

If chosen, you will also have the opportunity to present at Synchrony 2024 and/or participate in a roundtable discussion specifically for case studies.

Synchrony is the first and only international symposium on translational research in autism, that brings together academia, biotech, pharmaceutical companies and venture partners from around the world with the mission to improve health and quality of life of people with autism. This year’s Synchrony 2024 is taking place July 11-14 at Asilomar, California. Find out more here.